Tilray wins approval for in-house medical cannabis testing in Portugal

Portugal's medicines regulator approved Tilray's EU-GMP facility to conduct microbiological and chemical testing in-house, which the company says will shorten batch-release timelines and reduce outside-lab costs. Oklahoma laboratories and vertically integrated operators can treat the move as a process-control benchmark, while recognizing that local testing rules still require independent licensed laboratories.